41
Pharma & HealthcareAvoid
Nippon India Pharma
Nippon India · Direct–Growth · rank #12 / 18 Smart Score ke hisaab se
Data updated
Nippon India Pharma ka score 41/100 hai — 18 mein #12 Pharma & Healthcare fund (Avoid). Mazbooti: utaar-chadhaav (category mein 91th percentile) aur fund size (category mein 97th percentile). Kamzori: 3 saal ka return (category mein 5th percentile).
Trailing returns
index ke muqable: Nifty 500 (index-fund proxy)1 saal
11.7%
+8.9% index ke muqable
3 saal
19.4%
+8.0% index ke muqable
5 saal
13.5%
+3.2% index ke muqable
Launch se
17.6%
Saal-dar-saal performance
aakhri entry = is saal ab tak2021
25.1%
2022
-9.1%
2023
40.4%
2024
35.3%
2025
-2.5%
2026
12.7%
Risk metrics
Sharpe ratio
0.99
↑ jitna zyada, utna accha
Sortino ratio
1.43
↑ jitna zyada, utna accha
Std deviation
12.96
↓ jitna kam, utna accha
Alpha
9.12
↑ jitna zyada, utna accha
Beta
0.59
≈1 yaani market ke saath
Isi category ke aur funds
Research aur education ke liye — investment advice nahi.